Ischemia-modified albumin (IMA): a novel marker of vascular involvement in Behçet's disease?
暂无分享,去创建一个
[1] C. Erem,et al. THE RELATIONSHIP BETWEEN DIABETIC RETINOPATHY AND SERUM LEVELS OF ISCHEMIA-MODIFIED ALBUMIN AND MALONDIALDEHYDE , 2011, Retina.
[2] T. Ozlu,et al. Diagnostic value of pleural effusion ischaemia-modified albumin in patients with cardiac failure , 2011, Annals of clinical biochemistry.
[3] M. Topbaş,et al. The effect of anti-TNF agent on oxidation status in patients with ankylosing spondylitis , 2010, Clinical Rheumatology.
[4] M. Topbaş,et al. Effect of deep vein thrombosis on ischaemia-modified albumin levels , 2008, Emergency Medicine Journal.
[5] P. Collinson,et al. Ischaemia-modified albumin: clinical utility and pitfalls in measurement , 2008, Journal of Clinical Pathology.
[6] A. Kızıltunç,et al. Serum oxidant/antioxidant status in patients with Behçet's disease. , 2002, Annals of clinical and laboratory science.
[7] F. Akçay,et al. Serum Oxidant/Antioxidant Status in Patients with Systemic Lupus Erythematosus , 2002, Clinical chemistry and laboratory medicine.
[8] J. Kooner,et al. Vascular endothelial function and oxidative stress mechanisms in patients with Behçet's syndrome. , 2001, Journal of the American College of Cardiology.
[9] Y. Niwa,et al. Auto-oxidative damage in Behçet's disease--endothelial cell damage following the elevated oxygen radicals generated by stimulated neutrophils. , 1982, Clinical and Experimental Immunology.